X4 Pharmaceuticals (XFOR) EBIT Margin (2018 - 2026)
X4 Pharmaceuticals (XFOR) reported EBIT Margin of -186.13% for Q2 2026, up 1143.41 percentage points from -1329.55% a year earlier and up 563.72 percentage points from the prior quarter.
Powered by 
Analysis
X4 Pharmaceuticals (XFOR) EBIT Margin (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, X4 Pharmaceuticals' EBIT Margin came in at -554.71%, down 231.62 percentage points year-over-year; for FY2025, it was -247.44%, up 1176.14 percentage points from FY2024.
- EBIT Margin has a five-year change of +1748.36 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at -1423.58% in FY2024.
- The Q2 2026 figure ranks as the highest quarterly EBIT Margin since Q1 2025.
- Year over year, EBIT Margin gained in three of the last five quarters, with an average year-over-year change of -1472.53 percentage points.
- Per Business Quant data, the three quarters before Q2 2026 came in at -749.85% (Q1 2026), -922.86% (Q4 2025) and -1558.58% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 37.40% |
| 10 | X4 Pharmaceuticals | 366.40 Mn | -332.29 Mn | 7.19 Mn | -186.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -186.13% |
| Mar 31, 2026 | -749.85% |
| Dec 31, 2025 | -922.86% |
| Sep 30, 2025 | -1,558.58% |
| Jun 30, 2025 | -1,329.55% |
| Mar 31, 2025 | -32.78% |
| Dec 31, 2024 | -2,490.59% |
| Sep 30, 2024 | -6,160.71% |
| Jun 30, 2024 | 12,629.31% |
| Mar 31, 2020 | -352.70% |
| Dec 31, 2018 | -230.11% |
API Access
X4 Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=XFOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "XFOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=XFOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();